Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy

Clinicians should be aware of the potential for the pharmacologic activity of SGLT2 inhibitors to persist long after the standard drug clearance period of five half‐lives, the typical duration used to guide pre‐operative medication recommendations.

Detalles Bibliográficos
Autores principales: Bobrowski, David, Kumar, Reha, Wu, Peter E., Lapointe‐Shaw, Lauren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577244/
https://www.ncbi.nlm.nih.gov/pubmed/34786197
http://dx.doi.org/10.1002/ccr3.5057
_version_ 1784596034792456192
author Bobrowski, David
Kumar, Reha
Wu, Peter E.
Lapointe‐Shaw, Lauren
author_facet Bobrowski, David
Kumar, Reha
Wu, Peter E.
Lapointe‐Shaw, Lauren
author_sort Bobrowski, David
collection PubMed
description Clinicians should be aware of the potential for the pharmacologic activity of SGLT2 inhibitors to persist long after the standard drug clearance period of five half‐lives, the typical duration used to guide pre‐operative medication recommendations.
format Online
Article
Text
id pubmed-8577244
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85772442021-11-15 Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy Bobrowski, David Kumar, Reha Wu, Peter E. Lapointe‐Shaw, Lauren Clin Case Rep Case Report Clinicians should be aware of the potential for the pharmacologic activity of SGLT2 inhibitors to persist long after the standard drug clearance period of five half‐lives, the typical duration used to guide pre‐operative medication recommendations. John Wiley and Sons Inc. 2021-11-09 /pmc/articles/PMC8577244/ /pubmed/34786197 http://dx.doi.org/10.1002/ccr3.5057 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Bobrowski, David
Kumar, Reha
Wu, Peter E.
Lapointe‐Shaw, Lauren
Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy
title Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy
title_full Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy
title_fullStr Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy
title_full_unstemmed Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy
title_short Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy
title_sort prolonged ketosis and glycosuria secondary to sglt2 inhibitor therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577244/
https://www.ncbi.nlm.nih.gov/pubmed/34786197
http://dx.doi.org/10.1002/ccr3.5057
work_keys_str_mv AT bobrowskidavid prolongedketosisandglycosuriasecondarytosglt2inhibitortherapy
AT kumarreha prolongedketosisandglycosuriasecondarytosglt2inhibitortherapy
AT wupetere prolongedketosisandglycosuriasecondarytosglt2inhibitortherapy
AT lapointeshawlauren prolongedketosisandglycosuriasecondarytosglt2inhibitortherapy

Ejemplares similares